Ronald Blue Trust, Inc. Pacira Bio Sciences, Inc. Transaction History
Ronald Blue Trust, Inc.
- $7.98 Billion
- Q3 2024
A detailed history of Ronald Blue Trust, Inc. transactions in Pacira Bio Sciences, Inc. stock. As of the latest transaction made, Ronald Blue Trust, Inc. holds 59 shares of PCRX stock, worth $1,319. This represents 0.0% of its overall portfolio holdings.
Number of Shares
59
Previous 33
78.79%
Holding current value
$1,319
Previous $0
NaN%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding PCRX
# of Institutions
258Shares Held
50.1MCall Options Held
429KPut Options Held
391K-
Black Rock Inc. New York, NY8.01MShares$179 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.3MShares$118 Million0.0% of portfolio
-
Pacer Advisors, Inc. Malvern, PA4.96MShares$111 Million0.18% of portfolio
-
State Street Corp Boston, MA2.01MShares$45 Million0.0% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny1.98MShares$44.3 Million0.05% of portfolio
About Pacira BioSciences, Inc.
- Ticker PCRX
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 45,824,200
- Market Cap $1.02B
- Description
- Pacira BioSciences, Inc. provides non-opioid pain management and regenerative health solutions for healthcare practitioners and their patients in the United States. The company offers EXPAREL, a bupivacaine liposome injectable suspension; ZILRETTA, a triamcinolone acetonide extended-release injectable suspension; and iovera system, a non-opioid ...